Recent News
A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United StatesAdvances in Urology
Purpose. To estimate the US prevalence of Peyronie's disease (PD) from patient-reported data and to identify diagnosis and treatment patterns.
Methods. 11,420 US males ≥18 years old completed a brief web-based survey regarding the presence of PD, past treatments, and penile symptoms (Phase 1). Phase 1 respondents with PD diagnosis, history of treatment, or PD-related symptoms then completed a disease-specific survey (Phase 2).
Results. Estimated prevalence of PD ranged from 0.5% (diagnosis of PD) to 13% (diagnosis, treatment, or penile symptoms). Thirty-six percent of Phase 2 participants reported that penile symptoms interfered with sexual activities. Of participants who sought treatment for penile symptoms (n=128), 73% initially saw a primary care physician, 74% did not receive treatment from their first doctor, and 92% were not diagnosed with PD.
Conclusions. PD may be underdiagnosed/undertreated in the US. Improved awareness is needed of PD symptoms and treatment options among health care professionals.
Simultaneous Penile Lengthening and Penile Prosthesis Implantation in Patients with Peyronie's Disease, Refractory Erectile Dysfunction, and Severe Penile Shortening(title unknown)
Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie’s Disease.The journal of sexual medicine[TA]
Abern MR, Larsen S, Levine LA
Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie’s Disease. [JOURNAL ARTICLE]
J Sex Med 2011 Oct 24.
Abstract | Full Citation | Publisher Full Text | Find Related Articles